Progressing haemorrhagic stroke: categories, causes, mechanisms and managements

Shiyu Chen, Liuwang Zeng, Zhiping Hu, Shiyu Chen, Liuwang Zeng, Zhiping Hu

Abstract

Haemorrhagic stroke is a severe stroke subtype with high rates of morbidity and mortality. Although this condition has been recognised for a long time, the progressing haemorrhagic stroke has not received adequate attention, and it accounts for an even worse clinical outcome than the nonprogressing types of haemorrhagic stroke. In this review article, we categorised the progressing haemorrhagic stroke into acute progressing haemorrhagic stroke, subacute haemorrhagic stroke, and chronic progressing haemorrhagic stroke. Haematoma expansion, intraventricular haemorrhage, perihaematomal oedema, and inflammation, can all cause an acute progression of haemorrhagic stroke. Specific 'second peak' of perihaematomal oedema after intracerebral haemorrhage and 'tension haematoma' are the primary causes of subacute progression. For the chronic progressing haemorrhagic stroke, the occult vascular malformations, trauma, or radiologic brain surgeries can all cause a slowly expanding encapsulated haematoma. The mechanisms to each type of progressing haemorrhagic stroke is different, and the management of these three subtypes differs according to their causes and mechanisms. Conservative treatments are primarily considered in the acute progressing haemorrhagic stroke, whereas surgery is considered in the remaining two types.

Figures

Fig. 1
Fig. 1
Mechanism of acute progressing haemorrhagic stroke
Fig. 2
Fig. 2
Patient with ‘spot sign,’ demonstrating extravasation and haematoma expansion [166]. Reproduced from Wolters Kluwer Health with permission
Fig. 3
Fig. 3
Haematoma heterogeneity and haematoma growth border. These two patients were admitted to our hospital with the impression of spontaneous ICH. Patient 1: a CT on admission shows haematoma heterogeneity with an initial haematoma volume of 15 mL. b Repeated CT after 32 h shows a haematoma volume of 30 mL. Patient 2: c CT on admission shows haematoma growth border (black arrow). d Repeated CT after 10 h shows haematoma expansion with increased midline shift
Fig. 4
Fig. 4
A case of subacute progressing stroke. The patient was admitted to our hospital because of dysphagia, hemiparalysis, and conscious disturbance. a CT on hospital admission showed left parietal and frontal intracerebral haemorrhage. After the initial treatment, the patient regained consciousness. b 10 days after hospital admission, the patient became lethargic, and repeated CT showed an increased mass effect and midline shift, with enlargement of the perihaematomal oedema. Stronger osmotic therapy was applied immediately and the patient’s consciousness improved. c Repeated CT at 17 days post hospital admission showed that the initial haematoma shrank further, the density of the brain oedema decreased, and the mass effect alleviated modestly. d An enhanced CT at 17 days showed no ring-enhancement, eliminating the tension haematoma
Fig. 5
Fig. 5
Management of subacute progressing stroke
Fig. 6
Fig. 6
Mechanisms of CEICH

References

    1. Tranexamic acid for Intracerebral haemorrhage TICH-2: a pragmatic phase III prospective double blind randomised placebo controlled trial. doi: 10.1186/ISRCTN93732214. . Accessed 2 Feb 2014
    1. Agnihotri S, Czap A, Staff I, Fortunato G, McCullough LD. Peripheral leukocyte counts and outcomes after intracerebral hemorrhage. J Neuroinflammation. 2011;8:160. doi: 10.1186/1742-2094-8-160.
    1. Aguilar MI, Freeman WD. Treatment of coagulopathy in intracranial hemorrhage. Curr Treat Options Neurol. 2010;12:113–128. doi: 10.1007/s11940-010-0061-1.
    1. Aguilar MI, Hart RG, Kase CS, Freeman WD, Hoeben BJ, Garcia RC, Ansell JE, Mayer SA, Norrving B, Rosand J, Steiner T, Wijdicks EF, Yamaguchi T, Yasaka M. Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion. Mayo Clin Proc Mayo Clin. 2007;82:82–92. doi: 10.1016/S0025-6196(11)60970-1.
    1. Aiyagari V, Testai FD. Correction of coagulopathy in warfarin associated cerebral hemorrhage. Curr Opin Crit Care. 2009;15:87–92. doi: 10.1097/MCC.0b013e3283269e4d.
    1. Al-Shahi Salman R (2009) Haemostatic drug therapies for acute spontaneous intracerebral haemorrhage. Cochrane Database Syst Rev (4):CD005951
    1. Anderson CS, Heeley E, Huang Y, Wang J, Stapf C, Delcourt C, Lindley R, Robinson T, Lavados P, Neal B, Hata J, Arima H, Parsons M, Li Y, Wang J, Heritier S, Li Q, Woodward M, Simes RJ, Davis SM, Chalmers J, Investigators I. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med. 2013;368:2355–2365. doi: 10.1056/NEJMoa1214609.
    1. Anderson CS, Huang Y, Arima H, Heeley E, Skulina C, Parsons MW, Peng B, Li Q, Su S, Tao QL, Li YC, Jiang JD, Tai LW, Zhang JL, Xu E, Cheng Y, Morgenstern LB, Chalmers J, Wang JG, Investigators I. Effects of early intensive blood pressure-lowering treatment on the growth of hematoma and perihematomal edema in acute intracerebral hemorrhage: the Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT) Stroke; J Cereb Circ. 2010;41:307–312. doi: 10.1161/STROKEAHA.109.561795.
    1. Appelboom G, Piazza MA, Hwang BY, Carpenter A, Bruce SS, Mayer S, Connolly ES., Jr Severity of intraventricular extension correlates with level of admission glucose after intracerebral hemorrhage. Stroke; J Cereb Circ. 2011;42:1883–1888. doi: 10.1161/STROKEAHA.110.608166.
    1. Babu R, Bagley JH, Di C, Friedman AH, Adamson C. Thrombin and hemin as central factors in the mechanisms of intracerebral hemorrhage-induced secondary brain injury and as potential targets for intervention. Neurosurg Focus. 2012;32:E8. doi: 10.3171/2012.1.FOCUS11366.
    1. Balami JS, Buchan AM. Complications of intracerebral haemorrhage. Lancet Neurol. 2012;11:101–118. doi: 10.1016/S1474-4422(11)70264-2.
    1. Barras CD, Tress BM, Christensen S, Collins M, Desmond PM, Skolnick BE, Mayer SA, Davis SM, Recombinant Activated Factor VIIIHTI Quantitative CT densitometry for predicting intracerebral hemorrhage growth. AJNR Am J Neuroradiol. 2013;34:1139–1144. doi: 10.3174/ajnr.A3375.
    1. Barras CD, Tress BM, Christensen S, MacGregor L, Collins M, Desmond PM, Skolnick BE, Mayer SA, Broderick JP, Diringer MN, Steiner T, Davis SM. Density and shape as CT predictors of intracerebral hemorrhage growth. Stroke; J Cereb Circ. 2009;40:1325–1331. doi: 10.1161/STROKEAHA.108.536888.
    1. Bejot Y, Aboa-Eboule C, Hervieu M, Jacquin A, Osseby GV, Rouaud O, Giroud M. The deleterious effect of admission hyperglycemia on survival and functional outcome in patients with intracerebral hemorrhage. Stroke; J Cereb Circ. 2012;43:243–245. doi: 10.1161/STROKEAHA.111.632950.
    1. Bereczki D, Fekete I, Prado GF, Liu M (2007) Mannitol for acute stroke. Cochrane Database Syst Rev (3):CD001153
    1. Bhattathiri PS, Gregson B, Prasad KS, Mendelow AD, Investigators S. Intraventricular hemorrhage and hydrocephalus after spontaneous intracerebral hemorrhage: results from the STICH trial. Acta neurochir Suppl. 2006;96:65–68. doi: 10.1007/3-211-30714-1_16.
    1. Biffi A, Battey TW, Ayres AM, Cortellini L, Schwab K, Gilson AJ, Rost NS, Viswanathan A, Goldstein JN, Greenberg SM, Rosand J. Warfarin-related intraventricular hemorrhage: imaging and outcome. Neurology. 2011;77:1840–1846. doi: 10.1212/WNL.0b013e3182377e12.
    1. Birschel P, Ellul J, Barer D. Progressing stroke: towards an internationally agreed definition. Cerebrovasc Dis. 2004;17:242–252. doi: 10.1159/000076161.
    1. Broderick JP, Diringer MN, Hill MD, Brun NC, Mayer SA, Steiner T, Skolnick BE, Davis SM, Recombinant Activated Factor VIIIHTI Determinants of intracerebral hemorrhage growth: an exploratory analysis. Stroke; J Cereb Circ. 2007;38:1072–1075. doi: 10.1161/01.STR.0000258078.35316.30.
    1. Brott T, Broderick J, Kothari R, Barsan W, Tomsick T, Sauerbeck L, Spilker J, Duldner J, Khoury J. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke; J Cereb Circ. 1997;28:1–5. doi: 10.1161/01.STR.28.1.1.
    1. Brouwers HB, Goldstein JN, Romero JM, Rosand J. Clinical applications of the computed tomography angiography spot sign in acute intracerebral hemorrhage: a review. Stroke; J Cereb Circ. 2012;43:3427–3432. doi: 10.1161/STROKEAHA.112.664003.
    1. Brunswick AS, Hwang BY, Appelboom G, Hwang RY, Piazza MA, Connolly ES., Jr Serum biomarkers of spontaneous intracerebral hemorrhage induced secondary brain injury. J Neurol Sci. 2012;321:1–10. doi: 10.1016/j.jns.2012.06.008.
    1. Butcher KS, Baird T, MacGregor L, Desmond P, Tress B, Davis S. Perihematomal edema in primary intracerebral hemorrhage is plasma derived. Stroke; J Cereb Circ. 2004;35:1879–1885. doi: 10.1161/01.STR.0000131807.54742.1a.
    1. Cabral KP, Fraser GL, Duprey J, Gibbons BA, Hayes T, Florman JE, Seder DB. Prothrombin complex concentrates to reverse warfarin-induced coagulopathy in patients with intracranial bleeding. Clin Neurol Neurosurg. 2013;115:770–774. doi: 10.1016/j.clineuro.2012.07.006.
    1. Cakir E, Kuzeyli K, Usul H, Sayin OC, Kararslan G, Peksoylu B. Ruptured chronic encapsulated intracerebral hematoma in infancy: review of the literature with a case report. Child’s Nerv Syst: ChNS : Off J Int Soc Pediatr Neurosurg. 2006;22:436–439. doi: 10.1007/s00381-005-1157-x.
    1. Carhuapoma JR, Hanley DF, Banerjee M, Beauchamp NJ. Brain edema after human cerebral hemorrhage: a magnetic resonance imaging volumetric analysis. J Neurosurg Anesthesiol. 2003;15:230–233. doi: 10.1097/00008506-200307000-00010.
    1. Castillo J. Deteriorating stroke: diagnostic criteria, predictors, mechanisms and treatment. Cerebrovasc Dis. 1999;9(Suppl 3):1–8. doi: 10.1159/000047548.
    1. Chen NF, Wang YC, Shen CC, Jan YJ, Chen WH, Leu CH. Calcification and ossification of chronic encapsulated intracerebral haematoma: case report. J Clin Neurosci: Official J Neurosurg Soc Australas. 2004;11:527–530. doi: 10.1016/j.jocn.2003.06.008.
    1. Cosolo WC, Martinello P, Louis WJ, Christophidis N. Blood-brain barrier disruption using mannitol: time course and electron microscopy studies. Am J Physiol. 1989;256:R443–R447.
    1. Davis SM, Broderick J, Hennerici M, Brun NC, Diringer MN, Mayer SA, Begtrup K, Steiner T. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology. 2006;66:1175–1181. doi: 10.1212/01.wnl.0000208408.98482.99.
    1. de Lecinana MA, Huertas N, Egido JA, Muriel A, Garcia A, Ruiz-Ares G, Diez-Tejedor E, Fuentes B. Questionable reversal of anticoagulation in the therapeutic management of cerebral haemorrhage associated with vitamin K antagonists. Thromb Haemost. 2013;110:1145–1151. doi: 10.1160/TH13-04-0318.
    1. Delcourt C, Huang Y, Arima H, Chalmers J, Davis SM, Heeley EL, Wang J, Parsons MW, Liu G, Anderson CS, Investigators I. Hematoma growth and outcomes in intracerebral hemorrhage: the INTERACT1 study. Neurology. 2012;79:314–319. doi: 10.1212/WNL.0b013e318260cbba.
    1. Delgado Almandoz JE, Yoo AJ, Stone MJ, Schaefer PW, Goldstein JN, Rosand J, Oleinik A, Lev MH, Gonzalez RG, Romero JM. Systematic characterization of the computed tomography angiography spot sign in primary intracerebral hemorrhage identifies patients at highest risk for hematoma expansion: the spot sign score. Stroke; J Cereb Circ. 2009;40:2994–3000. doi: 10.1161/STROKEAHA.109.554667.
    1. Delgado Almandoz JE, Yoo AJ, Stone MJ, Schaefer PW, Oleinik A, Brouwers HB, Goldstein JN, Rosand J, Lev MH, Gonzalez RG, Romero JM. The spot sign score in primary intracerebral hemorrhage identifies patients at highest risk of in-hospital mortality and poor outcome among survivors. Stroke; J Cereb Circ. 2010;41:54–60. doi: 10.1161/STROKEAHA.109.565382.
    1. Demchuk AM, Dowlatshahi D, Rodriguez-Luna D, Molina CA, Blas YS, Dzialowski I, Kobayashi A, Boulanger JM, Lum C, Gubitz G, Padma V, Roy J, Kase CS, Kosior J, Bhatia R, Tymchuk S, Subramaniam S, Gladstone DJ, Hill MD, Aviv RI, Group PRSICs Prediction of haematoma growth and outcome in patients with intracerebral haemorrhage using the CT-angiography spot sign (PREDICT): a prospective observational study. Lancet Neurol. 2012;11:307–314. doi: 10.1016/S1474-4422(12)70038-8.
    1. Di Napoli M, Godoy DA, Campi V, del Valle M, Pinero G, Mirofsky M, Popa-Wagner A, Masotti L, Papa F, Rabinstein AA. C-reactive protein level measurement improves mortality prediction when added to the spontaneous intracerebral hemorrhage score. Stroke; J Cereb Circ. 2011;42:1230–1236. doi: 10.1161/STROKEAHA.110.604983.
    1. Diringer MN, Edwards DF. Admission to a neurologic/neurosurgical intensive care unit is associated with reduced mortality rate after intracerebral hemorrhage. Crit Care Med. 2001;29:635–640. doi: 10.1097/00003246-200103000-00031.
    1. Donovan FM, Pike CJ, Cotman CW, Cunningham DD. Thrombin induces apoptosis in cultured neurons and astrocytes via a pathway requiring tyrosine kinase and RhoA activities. J Neurosci: Off J Soc Neurosci. 1997;17:5316–5326.
    1. Dowlatshahi D, Smith EE, Flaherty ML, Ali M, Lyden P, Demchuk AM, Collaborators V. Small intracerebral haemorrhages are associated with less haematoma expansion and better outcomes. Int J Stroke: Off J Int Stroke Soc. 2011;6:201–206. doi: 10.1111/j.1747-4949.2010.00563.x.
    1. Ederies A, Demchuk A, Chia T, Gladstone DJ, Dowlatshahi D, Bendavit G, Wong K, Symons SP, Aviv RI. Postcontrast CT extravasation is associated with hematoma expansion in CTA spot negative patients. Stroke; J Cereb Circ. 2009;40:1672–1676. doi: 10.1161/STROKEAHA.108.541201.
    1. European Stroke Initiative Writing C. Writing Committee for the EEC. Steiner T, Kaste M, Forsting M, Mendelow D, Kwiecinski H, Szikora I, Juvela S, Marchel A, Chapot R, Cognard C, Unterberg A, Hacke W. Recommendations for the management of intracranial haemorrhage - part I: spontaneous intracerebral haemorrhage. The European Stroke Initiative Writing Committee and the Writing Committee for the EUSI Executive Committee. Cerebrovasc Dis. 2006;22:294–316. doi: 10.1159/000094831.
    1. Fernandes HM, Gregson B, Siddique S, Mendelow AD. Surgery in intracerebral hemorrhage. The uncertainty continues. Stroke; J Cereb Circ. 2000;31:2511–2516. doi: 10.1161/01.STR.31.10.2511.
    1. Fisher CM. Pathological observations in hypertensive cerebral hemorrhage. J Neuropathol Exp Neurol. 1971;30:536–550. doi: 10.1097/00005072-197107000-00015.
    1. Fiumara E, Gambacorta M, D’Angelo V, Ferrara M, Corona C. Chronic encapsulated intracerebral haematoma: pathogenetic and diagnostic considerations. J Neurol Neurosurg Psychiatry. 1989;52:1296–1299. doi: 10.1136/jnnp.52.11.1296.
    1. Flaherty ML, Kissela B, Woo D, Kleindorfer D, Alwell K, Sekar P, Moomaw CJ, Haverbusch M, Broderick JP. The increasing incidence of anticoagulant-associated intracerebral hemorrhage. Neurology. 2007;68:116–121. doi: 10.1212/01.wnl.0000250340.05202.8b.
    1. Flemming KD, Wijdicks EF, Louis EK, Li H. Predicting deterioration in patients with lobar haemorrhages. J Neurol Neurosurg Psychiatry. 1999;66:600–605. doi: 10.1136/jnnp.66.5.600.
    1. Flibotte JJ, Hagan N, O’Donnell J, Greenberg SM, Rosand J. Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage. Neurology. 2004;63:1059–1064. doi: 10.1212/01.WNL.0000138428.40673.83.
    1. Florczak-Rzepka M, Grond-Ginsbach C, Montaner J, Steiner T. Matrix metalloproteinases in human spontaneous intracerebral hemorrhage: an update. Cerebrovasc Dis. 2012;34:249–262. doi: 10.1159/000341686.
    1. Foroughi M, Kemeny AA, Lehecka M, Wons J, Kajdi L, Hatfield R, Marks S. Operative intervention for delayed symptomatic radionecrotic masses developing following stereotactic radiosurgery for cerebral arteriovenous malformations–case analysis and literature review. Acta Neurochir (Wien) 2010;152:803–815. doi: 10.1007/s00701-009-0581-1.
    1. Fujii Y, Takeuchi S, Sasaki O, Minakawa T, Tanaka R. Multivariate analysis of predictors of hematoma enlargement in spontaneous intracerebral hemorrhage. Stroke; J Cereb Circ. 1998;29:1160–1166. doi: 10.1161/01.STR.29.6.1160.
    1. Fujii Y, Tanaka R, Takeuchi S, Koike T, Minakawa T, Sasaki O. Hematoma enlargement in spontaneous intracerebral hemorrhage. J Neurosurg. 1994;80:51–57. doi: 10.3171/jns.1994.80.1.0051.
    1. Fulesdi B, Kovacs KR, Bereczki D, Bagyi P, Fekete I, Csiba L (2013) Computed tomography and transcranial doppler findings in acute and subacute phases of intracerebral hemorrhagic stroke. J Neuroimaging: Off J Am Soc Neuroimaging. doi:10.1111/j.1552-6569.2012.00776.x
    1. Fung C, Murek M, Z’Graggen WJ, Krahenbuhl AK, Gautschi OP, Schucht P, Gralla J, Schaller K, Arnold M, Fischer U, Mattle HP, Raabe A, Beck J. Decompressive hemicraniectomy in patients with supratentorial intracerebral hemorrhage. Stroke; J Cereb Circ. 2012;43:3207–3211. doi: 10.1161/STROKEAHA.112.666537.
    1. Gautier JC. Stroke-in-progression. Stroke; J Cereb Circ. 1985;16:729–733. doi: 10.1161/01.STR.16.4.729.
    1. Gebel JM, Brott TG, Sila CA, Tomsick TA, Jauch E, Salisbury S, Khoury J, Miller R, Pancioli A, Duldner JE, Topol EJ, Broderick JP. Decreased perihematomal edema in thrombolysis-related intracerebral hemorrhage compared with spontaneous intracerebral hemorrhage. Stroke; J Cereb Circ. 2000;31:596–600. doi: 10.1161/01.STR.31.3.596.
    1. Gebel JM, Jr, Jauch EC, Brott TG, Khoury J, Sauerbeck L, Salisbury S, Spilker J, Tomsick TA, Duldner J, Broderick JP. Natural history of perihematomal edema in patients with hyperacute spontaneous intracerebral hemorrhage. Stroke; J Cereb Circ. 2002;33:2631–2635. doi: 10.1161/01.STR.0000035284.12699.84.
    1. Gingrich MB, Junge CE, Lyuboslavsky P, Traynelis SF. Potentiation of NMDA receptor function by the serine protease thrombin. J Neurosci: Off J Soc Neurosci. 2000;20:4582–4595.
    1. Godoy DA, Pinero GR, Svampa S, Papa F, Di Napoli M. Hyperglycemia and short-term outcome in patients with spontaneous intracerebral hemorrhage. Neurocrit Care. 2008;9:217–229. doi: 10.1007/s12028-008-9063-1.
    1. Goldstein J, Brouwers H, Romero J, McNamara K, Schwab K, Greenberg S, Rosand J. SCORE-IT: the Spot Sign score in restricting ICH growth horizontal line an Atach-II ancillary study. J Vasc Interv Neurol. 2012;5:20–25.
    1. Goldstein JN, Thomas SH, Frontiero V, Joseph A, Engel C, Snider R, Smith EE, Greenberg SM, Rosand J. Timing of fresh frozen plasma administration and rapid correction of coagulopathy in warfarin-related intracerebral hemorrhage. Stroke; J Cereb Circ. 2006;37:151–155. doi: 10.1161/01.STR.0000195047.21562.23.
    1. Gong Y, Xi GH, Keep RF, Hoff JT, Hua Y. Complement inhibition attenuates brain edema and neurological deficits induced by thrombin. Acta neurochir Suppl. 2005;95:389–392. doi: 10.1007/3-211-32318-X_79.
    1. Gray CS, Hildreth AJ, Sandercock PA, O’Connell JE, Johnston DE, Cartlidge NE, Bamford JM, James OF, Alberti KG, Collaboration GT. Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK) Lancet Neurol. 2007;6:397–406. doi: 10.1016/S1474-4422(07)70080-7.
    1. Gregson BA, Broderick JP, Auer LM, Batjer H, Chen XC, Juvela S, Morgenstern LB, Pantazis GC, Teernstra OP, Wang WZ, Zuccarello M, Mendelow AD. Individual patient data subgroup meta-analysis of surgery for spontaneous supratentorial intracerebral hemorrhage. Stroke; J Cereb Circ. 2012;43:1496–1504. doi: 10.1161/STROKEAHA.111.640284.
    1. Greiner-Perth R, Neubauer U, Schenke H. Chronic encapsulated intracerebral hematoma—a well-defined disease. Report on two cases and review of the literature. Neurosurg Rev. 1997;20:231–238. doi: 10.1007/BF01105893.
    1. Hallevi H, Abraham AT, Barreto AD, Grotta JC, Savitz SI. The spot sign in intracerebral hemorrhage: the importance of looking for contrast extravasation. Cerebrovasc Dis. 2010;29:217–220. doi: 10.1159/000267842.
    1. Hallevi H, Albright KC, Aronowski J, Barreto AD, Martin-Schild S, Khaja AM, Gonzales NR, Illoh K, Noser EA, Grotta JC. Intraventricular hemorrhage: anatomic relationships and clinical implications. Neurology. 2008;70:848–852. doi: 10.1212/01.wnl.0000304930.47751.75.
    1. Hanley DF. Intraventricular hemorrhage: severity factor and treatment target in spontaneous intracerebral hemorrhage. Stroke; J Cereb Circ. 2009;40:1533–1538. doi: 10.1161/STROKEAHA.108.535419.
    1. Herrick DB, Ziai WC, Thompson CB, Lane K, McBee NA, Hanley DF. Systemic hematologic status following intraventricular recombinant tissue-type plasminogen activator for intraventricular hemorrhage: the CLEAR IVH Study Group. Stroke; J Cereb Circ. 2011;42:3631–3633. doi: 10.1161/STROKEAHA.111.625749.
    1. Hirsh LF, Spector HB, Bogdanoff BM. Chronic encapsulated intracerebral hematoma. Neurosurgery. 1981;9:169–172. doi: 10.1227/00006123-198108000-00011.
    1. Ho CL, Ang CB, Lee KK, Ng IH. Effects of glycaemic control on cerebral neurochemistry in primary intracerebral haemorrhage. J Clin Neurosci: Off J Neurosurg Soc Australas. 2008;15:428–433. doi: 10.1016/j.jocn.2006.08.011.
    1. Hu S, Xi G, Jin H, He Y, Keep RF, Hua Y. Thrombin-induced autophagy: a potential role in intracerebral hemorrhage. Brain Res. 2011;1424:60–66. doi: 10.1016/j.brainres.2011.09.062.
    1. Hua Y, Keep RF, Hoff JT, Xi G. Brain injury after intracerebral hemorrhage: the role of thrombin and iron. Stroke; J Cereb Circ. 2007;38:759–762. doi: 10.1161/01.STR.0000247868.97078.10.
    1. Hua Y, Wu J, Keep RF, Nakamura T, Hoff JT, Xi G. Tumor necrosis factor-alpha increases in the brain after intracerebral hemorrhage and thrombin stimulation. Neurosurgery. 2006;58:542–550. doi: 10.1227/.
    1. Huang FP, Xi G, Keep RF, Hua Y, Nemoianu A, Hoff JT. Brain edema after experimental intracerebral hemorrhage: role of hemoglobin degradation products. J Neurosurg. 2002;96:287–293. doi: 10.3171/jns.2002.96.2.0287.
    1. Huang H, Liu Z, Kang G, Li S, Tian Z. Diagnosis and treatment of hypertensive tension hematoma. Med J Chin PLA. 1996;21:2.
    1. Huhtakangas J, Tetri S, Juvela S, Saloheimo P, Bode MK, Karttunen V, Karajamaki A, Hillbom M (2012) Improved survival of patients with warfarin-associated intracerebral haemorrhage: a retrospective longitudinal population-based study. Int J Stroke: Off J Int Stroke Soc. doi:10.1111/j.1747-4949.2012.00926.x
    1. Huttner HB, Schellinger PD, Hartmann M, Kohrmann M, Juettler E, Wikner J, Mueller S, Meyding-Lamade U, Strobl R, Mansmann U, Schwab S, Steiner T. Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrates. Stroke; J Cereb Circ. 2006;37:1465–1470. doi: 10.1161/01.STR.0000221786.81354.d6.
    1. Ikram MA, Wieberdink RG, Koudstaal PJ. International epidemiology of intracerebral hemorrhage. Curr Atheroscler Rep. 2012;14:300–306. doi: 10.1007/s11883-012-0252-1.
    1. Inaji M, Tomita H, Tone O, Tamaki M, Suzuki R, Ohno K. Chronological changes of perihematomal edema of human intracerebral hematoma. Acta neurochir Suppl. 2003;86:445–448.
    1. Intercollegiate Stroke Working Party . National clinical guideline for stroke. London: Royal College of Physicians; 2012.
    1. Ji N, Lu JJ, Zhao YL, Wang S, Zhao JZ. Imaging and clinical prognostic indicators for early hematoma enlargement after spontaneous intracerebral hemorrhage. Neurol Res. 2009;31:362–366. doi: 10.1179/174313209X444035.
    1. Jiang Y, Wu J, Hua Y, Keep RF, Xiang J, Hoff JT, Xi G. Thrombin-receptor activation and thrombin-induced brain tolerance. J Cereb Blood Flow Metab: Off J Int Soc Cereb Blood Flow Metab. 2002;22:404–410. doi: 10.1097/00004647-200204000-00004.
    1. Jorgensen HS, Nakayama H, Raaschou HO, Olsen TS. Effect of blood pressure and diabetes on stroke in progression. Lancet. 1994;344:156–159. doi: 10.1016/S0140-6736(94)92757-X.
    1. Karepov VG, Gur AY, Bova I, Aronovich BD, Bornstein NM. Stroke-in-evolution: infarct-inherent mechanisms versus systemic causes. Cerebrovasc Dis. 2006;21:42–46. doi: 10.1159/000089593.
    1. Kaufmann AM, Cardoso ER. Aggravation of vasogenic cerebral edema by multiple-dose mannitol. J Neurosurg. 1992;77:584–589. doi: 10.3171/jns.1992.77.4.0584.
    1. Kawakita K, Kawai N, Kuroda Y, Yasashita S, Nagao S. Expression of matrix metalloproteinase-9 in thrombin-induced brain edema formation in rats. J Stroke Cerebrovasc Dis: Off J Natl Stroke Assoc. 2006;15:88–95. doi: 10.1016/j.jstrokecerebrovasdis.2006.01.002.
    1. Kazui S, Minematsu K, Yamamoto H, Sawada T, Yamaguchi T. Predisposing factors to enlargement of spontaneous intracerebral hematoma. Stroke; J Cereb Circ. 1997;28:2370–2375. doi: 10.1161/01.STR.28.12.2370.
    1. Kazui S, Naritomi H, Yamamoto H, Sawada T, Yamaguchi T. Enlargement of spontaneous intracerebral hemorrhage. Incidence and time course. Stroke; J Cereb Circ. 1996;27:1783–1787. doi: 10.1161/01.STR.27.10.1783.
    1. Kimura K, Iguchi Y, Inoue T, Shibazaki K, Matsumoto N, Kobayashi K, Yamashita S. Hyperglycemia independently increases the risk of early death in acute spontaneous intracerebral hemorrhage. J Neurol Sci. 2007;255:90–94. doi: 10.1016/j.jns.2007.02.005.
    1. Koch S, Romano JG, Forteza AM, Otero CM, Rabinstein AA. Rapid blood pressure reduction in acute intracerebral hemorrhage: feasibility and safety. Neurocrit Care. 2008;8:316–321. doi: 10.1007/s12028-008-9085-8.
    1. Koenig MA, Bryan M, Lewin JL, 3rd, Mirski MA, Geocadin RG, Stevens RD. Reversal of transtentorial herniation with hypertonic saline. Neurology. 2008;70:1023–1029. doi: 10.1212/01.wnl.0000304042.05557.60.
    1. Kurita H, Sasaki T, Kawamoto S, Taniguchi M, Kitanaka C, Nakaguchi H, Kirino T. Chronic encapsulated expanding hematoma in association with gamma knife stereotactic radiosurgery for a cerebral arteriovenous malformation. Case report. J Neurosurg. 1996;84:874–878. doi: 10.3171/jns.1996.84.5.0874.
    1. Kwan J, Hand P. Early neurological deterioration in acute stroke: clinical characteristics and impact on outcome. QJM: Mon J Assoc Physicians. 2006;99:625–633. doi: 10.1093/qjmed/hcl082.
    1. Langhorne P, Fearon P, Ronning OM, Kaste M, Palomaki H, Vemmos K, Kalra L, Indredavik B, Blomstrand C, Rodgers H, Dennis MS, Al-Shahi Salman R, Stroke Unit Trialists C Stroke unit care benefits patients with intracerebral hemorrhage: systematic review and meta-analysis. Stroke; J Cereb Circ. 2013;44:3044–3049. doi: 10.1161/STROKEAHA.113.001564.
    1. Lauer A, Pfeilschifter W, Schaffer CB, Lo EH, Foerch C. Intracerebral haemorrhage associated with antithrombotic treatment: translational insights from experimental studies. Lancet Neurol. 2013;12:394–405. doi: 10.1016/S1474-4422(13)70049-8.
    1. Lee CC, Pan DH, Ho DM, Wu HM, Chung WY, Liu KD, Guo WY, Shih YH. Chronic encapsulated expanding hematoma after gamma knife stereotactic radiosurgery for cerebral arteriovenous malformation. Clin Neurol Neurosurg. 2011;113:668–671. doi: 10.1016/j.clineuro.2011.03.010.
    1. Lee JY, King C, Stradling D, Warren M, Nguyen D, Lee J, Riola MA, Montoya R, Patel D, Le VH, Welbourne SJ, Cramer SC (2012) Influence of hematoma location on acute mortality after intracerebral hemorrhage. J Neuroimaging: Off J Am Soc Neuroimaging. doi:10.1111/j.1552-6569.2012.00766.x
    1. Lee SH, Kim BJ, Bae HJ, Lee JS, Lee J, Park BJ, Yoon BW. Effects of glucose level on early and long-term mortality after intracerebral haemorrhage: the Acute Brain Bleeding Analysis Study. Diabetologia. 2010;53:429–434. doi: 10.1007/s00125-009-1617-z.
    1. Lee ST, Chu K, Jung KH, Kim J, Kim EH, Kim SJ, Sinn DI, Ko SY, Kim M, Roh JK. Memantine reduces hematoma expansion in experimental intracerebral hemorrhage, resulting in functional improvement. J Cereb Blood Flow Metab: Off J Int Soc Cereb Blood Flow Metab. 2006;26:536–544. doi: 10.1038/sj.jcbfm.9600213.
    1. Leira R, Davalos A, Silva Y, Gil-Peralta A, Tejada J, Garcia M, Castillo J, Stroke Project CDGotSNS Early neurologic deterioration in intracerebral hemorrhage: predictors and associated factors. Neurology. 2004;63:461–467. doi: 10.1212/.
    1. Li N, Wang Y, Wang W, Ma L, Xue J, Weissenborn K, Dengler R, Worthmann H, Wang DZ, Gao P, Liu L, Wang Y, Zhao X. Contrast extravasation on computed tomography angiography predicts clinical outcome in primary intracerebral hemorrhage: a prospective study of 139 cases. Stroke; J Cereb Circ. 2011;42:3441–3446. doi: 10.1161/STROKEAHA.111.623405.
    1. Lin CY, Chen Y, Tseng SH. Chronic encapsulated intracerebral haematoma. J Clin Neurosci: Off J Neurosurg Soc Australas. 2007;14:58–61. doi: 10.1016/j.jocn.2006.01.050.
    1. Liu DZ, Ander BP, Xu H, Shen Y, Kaur P, Deng W, Sharp FR. Blood-brain barrier breakdown and repair by Src after thrombin-induced injury. Ann Neurol. 2010;67:526–533. doi: 10.1002/ana.21924.
    1. Liu J, Gao BB, Clermont AC, Blair P, Chilcote TJ, Sinha S, Flaumenhaft R, Feener EP. Hyperglycemia-induced cerebral hematoma expansion is mediated by plasma kallikrein. Nat Med. 2011;17:206–210. doi: 10.1038/nm.2295.
    1. Liu J, Huang Y, Wang A. Diagnosis and treatment of intracerebral tension hematoma following cerebral hemorrhage. J Int Neurol Neurosurg. 2009;36:3.
    1. Maas MB, Nemeth AJ, Rosenberg NF, Kosteva AR, Prabhakaran S, Naidech AM. Delayed intraventricular hemorrhage is common and worsens outcomes in intracerebral hemorrhage. Neurology. 2013;80:1295–1299. doi: 10.1212/WNL.0b013e31828ab2a7.
    1. Masotti L, Di Napoli M, Godoy DA, Rafanelli D, Liumbruno G, Koumpouros N, Landini G, Pampana A, Cappelli R, Poli D, Prisco D. The practical management of intracerebral hemorrhage associated with oral anticoagulant therapy. Int J Stroke: Off J Int Stroke Soc. 2011;6:228–240. doi: 10.1111/j.1747-4949.2011.00595.x.
    1. Masuzawa T, Saito K, Shimabukuro H, Iwasa H, Sato F. Chronic encapsulated hematomas in the brain. Acta Neuropathol. 1985;66:24–28. doi: 10.1007/BF00698291.
    1. Mayer SA. Ultra-early hemostatic therapy for intracerebral hemorrhage. Stroke; J Cereb Circ. 2003;34:224–229. doi: 10.1161/01.STR.0000046458.67968.E4.
    1. Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, Skolnick BE, Steiner T, Investigators FT. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2008;358:2127–2137. doi: 10.1056/NEJMoa0707534.
    1. Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, Skolnick BE, Steiner T, Recombinant Activated Factor VIIIHTI Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2005;352:777–785. doi: 10.1056/NEJMoa042991.
    1. Mayer SA, Rincon F. Treatment of intracerebral haemorrhage. Lancet Neurol. 2005;4:662–672. doi: 10.1016/S1474-4422(05)70195-2.
    1. Mayer SA, Sacco RL, Shi T, Mohr JP. Neurologic deterioration in non comatose patients with supratentorial intracerebral hemorrhage. Neurology. 1994;44:1379–1384. doi: 10.1212/WNL.44.8.1379.
    1. Mendelow AD, Gregson BA, Fernandes HM, Murray GD, Teasdale GM, Hope DT, Karimi A, Shaw MD, Barer DH, Investigators S Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet. 2005;365:387–397. doi: 10.1016/S0140-6736(05)70233-6.
    1. Meretoja A, Churilov L, Campbell BC, Aviv RI, Yassi N, Barras C, Mitchell P, Yan B, Nandurkar H, Bladin C, Wijeratne T, Spratt NJ, Jannes J, Sturm J, Rupasinghe J, Zavala J, Lee A, Kleinig T, Markus R, Delcourt C, Mahant N, Parsons MW, Levi C, Anderson CS, Donnan GA, Davis SM (2013) The Spot sign and Tranexamic acid On Preventing ICH growth-Australasia Trial (STOP-AUST): Protocol of a phase II randomized, placebo-controlled, double-blind, multicenter trial. Int J Stroke: Off J Int Stroke Soc. doi:10.1111/ijs.12132
    1. Millikan CH, Bauer RB, Goldschmidt J. A classification and outline of cerebrovascular diseases. II. Stroke; J Cereb Circ. 1975;6:564–616. doi: 10.1161/01.STR.6.5.564.
    1. Millikan CH, McDowell FH. Treatment of progressing stroke. Prog Cardiovasc Dis. 1980;22:397–414. doi: 10.1016/0033-0620(80)90015-8.
    1. Misra UK, Kalita J, Ranjan P, Mandal SK. Mannitol in intracerebral hemorrhage: a randomized controlled study. J Neurol Sci. 2005;234:41–45. doi: 10.1016/j.jns.2005.03.038.
    1. Moller T, Hanisch UK, Ransom BR. Thrombin-induced activation of cultured rodent microglia. J Neurochem. 2000;75:1539–1547. doi: 10.1046/j.1471-4159.2000.0751539.x.
    1. Monma S, Ohno K, Hata H, Komatsu K, Ichimura K, Hirakawa K. Cavernous angioma with encapsulated intracerebral hematoma: report of two cases. Surg Neurol. 1990;34:245–249. doi: 10.1016/0090-3019(90)90135-C.
    1. Morgenstern LB, Hemphill JC, 3rd, Anderson C, Becker K, Broderick JP, Connolly ES, Jr, Greenberg SM, Huang JN, MacDonald RL, Messe SR, Mitchell PH, Selim M, Tamargo RJ. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke; J Cereb Circ. 2010;41:2108–2129. doi: 10.1161/STR.0b013e3181ec611b.
    1. Morgenstern LB, Hemphill JC, 3rd, Anderson C, Becker K, Broderick JP, Connolly ES, Jr, Greenberg SM, Huang JN, MacDonald RL, Messe SR, Mitchell PH, Selim M, Tamargo RJ, American Heart Association Stroke C. Council on Cardiovascular N Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke; J Cereb Circ. 2010;41:2108–2129. doi: 10.1161/STR.0b013e3181ec611b.
    1. Morioka J, Fujii M, Kato S, Fujisawa H, Akimura T, Suzuki M, Kobayashi S. Surgery for spontaneous intracerebral hemorrhage has greater remedial value than conservative therapy. Surg Neurol. 2006;65:67–72. doi: 10.1016/j.surneu.2005.03.023.
    1. Mould WA, Carhuapoma JR, Muschelli J, Lane K, Morgan TC, McBee NA, Bistran-Hall AJ, Ullman NL, Vespa P, Martin NA, Awad I, Zuccarello M, Hanley DF, Investigators M. Minimally invasive surgery plus recombinant tissue-type plasminogen activator for intracerebral hemorrhage evacuation decreases perihematomal edema. Stroke; J Cereb Circ. 2013;44:627–634. doi: 10.1161/STROKEAHA.111.000411.
    1. Naff N, Williams MA, Keyl PM, Tuhrim S, Bullock MR, Mayer SA, Coplin W, Narayan R, Haines S, Cruz-Flores S, Zuccarello M, Brock D, Awad I, Ziai WC, Marmarou A, Rhoney D, McBee N, Lane K, Hanley DF., Jr Low-dose recombinant tissue-type plasminogen activator enhances clot resolution in brain hemorrhage: the intraventricular hemorrhage thrombolysis trial. Stroke; J Cereb Circ. 2011;42:3009–3016. doi: 10.1161/STROKEAHA.110.610949.
    1. Naff NJ, Hanley DF, Keyl PM, Tuhrim S, Kraut M, Bederson J, Bullock R, Mayer SA, Schmutzhard E. Intraventricular thrombolysis speeds blood clot resolution: results of a pilot, prospective, randomized, double-blind, controlled trial. Neurosurgery. 2004;54:577–583. doi: 10.1227/01.NEU.0000108422.10842.60.
    1. Nakamizo A, Suzuki SO, Saito N, Shono T, Matsumoto K, Onaka S, Mizoguchi M, Sasaki T. Clinicopathological study on chronic encapsulated expanding hematoma associated with incompletely obliterated AVM after stereotactic radiosurgery. Acta Neurochir (Wien) 2011;153:883–893. doi: 10.1007/s00701-010-0829-9.
    1. National Stroke Foundation (2010) Clinical Guidelines for Stroke Management 2010
    1. Nieuwkamp DJ, de Gans K, Rinkel GJ, Algra A. Treatment and outcome of severe intraventricular extension in patients with subarachnoid or intracerebral hemorrhage: a systematic review of the literature. J Neurol. 2000;247:117–121. doi: 10.1007/PL00007792.
    1. Ohwaki K, Yano E, Nagashima H, Hirata M, Nakagomi T, Tamura A. Blood pressure management in acute intracerebral hemorrhage: relationship between elevated blood pressure and hematoma enlargement. Stroke; J Cereb Circ. 2004;35:1364–1367. doi: 10.1161/01.STR.0000128795.38283.4b.
    1. Piironen K, Putaala J, Rosso C, Samson Y. Glucose and acute stroke: evidence for an interlude. Stroke; J Cereb Circ. 2012;43:898–902. doi: 10.1161/STROKEAHA.111.631218.
    1. Poungvarin N, Bhoopat W, Viriyavejakul A, Rodprasert P, Buranasiri P, Sukondhabhant S, Hensley MJ, Strom BL. Effects of dexamethasone in primary supratentorial intracerebral hemorrhage. N Engl J Med. 1987;316:1229–1233. doi: 10.1056/NEJM198705143162001.
    1. Pozzati E, Giuliani G, Gaist G, Piazza G, Vergoni G. Chronic expanding intracerebral hematoma. J Neurosurg. 1986;65:611–614. doi: 10.3171/jns.1986.65.5.0611.
    1. Prasad K, Mendelow AD, Gregson B (2008) Surgery for primary supratentorial intracerebral haemorrhage. Cochrane Database Syst Rev (4):CD000200
    1. Qureshi AI. Acute hypertensive response in patients with stroke: pathophysiology and management. Circulation. 2008;118:176–187. doi: 10.1161/CIRCULATIONAHA.107.723874.
    1. Qureshi AI, Mendelow AD, Hanley DF. Intracerebral haemorrhage. Lancet. 2009;373:1632–1644. doi: 10.1016/S0140-6736(09)60371-8.
    1. Qureshi AI, Palesch YY, Martin R, Novitzke J, Cruz-Flores S, Ehtisham A, Ezzeddine MA, Goldstein JN, Hussein HM, Suri MF, Tariq N. Effect of systolic blood pressure reduction on hematoma expansion, perihematomal edema, and 3-month outcome among patients with intracerebral hemorrhage: results from the antihypertensive treatment of acute cerebral hemorrhage study. Arch Neurol. 2010;67:570–576. doi: 10.1001/archneurol.2010.61.
    1. Qureshi AI, Palesch YY, Martin R, Novitzke J, Cruz-Flores S, Ehtisham A, Ezzeddine MA, Goldstein JN, Kirmani JF, Hussein HM, Suri MF, Tariq N, Liu Y, Investigators A. Association of serum glucose concentrations during acute hospitalization with hematoma expansion, perihematomal edema, and three month outcome among patients with intracerebral hemorrhage. Neurocrit Care. 2011;15:428–435. doi: 10.1007/s12028-011-9541-8.
    1. Qureshi AI, Wilson DA, Traystman RJ. Treatment of elevated intracranial pressure in experimental intracerebral hemorrhage: comparison between mannitol and hypertonic saline. Neurosurgery. 1999;44:1055–1063. doi: 10.1097/00006123-199905000-00064.
    1. Rabinstein AA, Atkinson JL, Wijdicks EF. Emergency craniotomy in patients worsening due to expanded cerebral hematoma: to what purpose? Neurology. 2002;58:1367–1372. doi: 10.1212/WNL.58.9.1367.
    1. Rapoport SI. Osmotic opening of the blood-brain barrier: principles, mechanism, and therapeutic applications. Cell Mol Neurobiol. 2000;20:217–230. doi: 10.1023/A:1007049806660.
    1. Rincon F, Mayer SA. The epidemiology of intracerebral hemorrhage in the United States from 1979 to 2008. Neurocrit Care. 2013;19:95–102. doi: 10.1007/s12028-012-9793-y.
    1. Roda JM, Carceller F, Perez-Higueras A, Morales C. Encapsulated intracerebral hematomas: a defined entity. Case report. J Neurosurg. 1993;78:829–833. doi: 10.3171/jns.1993.78.5.0829.
    1. Rodriguez-Luna D, Rubiera M, Ribo M, Coscojuela P, Pagola J, Pineiro S, Ibarra B, Meler P, Maisterra O, Romero F, Alvarez-Sabin J, Molina CA. Serum low-density lipoprotein cholesterol level predicts hematoma growth and clinical outcome after acute intracerebral hemorrhage. Stroke; J Cereb Circ. 2011;42:2447–2452. doi: 10.1161/STROKEAHA.110.609461.
    1. Rosand J, Eckman MH, Knudsen KA, Singer DE, Greenberg SM. The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med. 2004;164:880–884. doi: 10.1001/archinte.164.8.880.
    1. Rosand J, Hylek EM, O’Donnell HC, Greenberg SM. Warfarin-associated hemorrhage and cerebral amyloid angiopathy: a genetic and pathologic study. Neurology. 2000;55:947–951. doi: 10.1212/WNL.55.7.947.
    1. Sakaida H, Sakakura M, Tochio H, Nakao K, Taniguchi A, Yabana T. Chronic encapsulated intracerebral hematoma associated with angiographically occult arteriovenous malformation–case report. Neurol Med Chir. 1993;33:638–642. doi: 10.2176/nmc.33.638.
    1. Schlunk F, Van Cott EM, Hayakawa K, Pfeilschifter W, Lo EH, Foerch C. Recombinant activated coagulation factor VII and prothrombin complex concentrates are equally effective in reducing hematoma volume in experimental warfarin-associated intracerebral hemorrhage. Stroke; J Cereb Circ. 2012;43:246–249. doi: 10.1161/STROKEAHA.111.629360.
    1. Silva Y, Leira R, Tejada J, Lainez JM, Castillo J, Davalos A, Stroke Project CDGotSNS Molecular signatures of vascular injury are associated with early growth of intracerebral hemorrhage. Stroke; J Cereb Circ. 2005;36:86–91. doi: 10.1161/01.STR.0000149615.51204.0b.
    1. Sorimachi T, Fujii Y. Early neurological change in patients with spontaneous supratentorial intracerebral hemorrhage. J Clin Neurosci: Off J Neurosurg Soc Australas. 2010;17:1367–1371. doi: 10.1016/j.jocn.2010.02.024.
    1. Staykov D, Wagner I, Volbers B, Hauer EM, Doerfler A, Schwab S, Bardutzky J. Natural course of perihemorrhagic edema after intracerebral hemorrhage. Stroke; J Cereb Circ. 2011;42:2625–2629. doi: 10.1161/STROKEAHA.111.618611.
    1. Steiner T, Diringer MN, Schneider D, Mayer SA, Begtrup K, Broderick J, Skolnick BE, Davis SM. Dynamics of intraventricular hemorrhage in patients with spontaneous intracerebral hemorrhage: risk factors, clinical impact, and effect of hemostatic therapy with recombinant activated factor VII. Neurosurgery. 2006;59:767–773. doi: 10.1227/01.NEU.0000232837.34992.32.
    1. Stroke Unit Trialists C Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev. 2013;9:CD000197.
    1. Sumer M, Ozdemir I, Erturk O. Progression in acute ischemic stroke: frequency, risk factors and prognosis. J Clin Neurosci: Off J Neurosurg Soc Australas. 2003;10:177–180. doi: 10.1016/S0967-5868(02)00325-9.
    1. Sun W, Peacock A, Becker J, Phillips-Bute B, Laskowitz DT, James ML. Correlation of leukocytosis with early neurological deterioration following supratentorial intracerebral hemorrhage. J Clin Neurosci: Off J Neurosurg Soc Australas. 2012;19:1096–1100. doi: 10.1016/j.jocn.2011.11.020.
    1. Sykora M, Diedler J, Rupp A, Turcani P, Rocco A, Steiner T. Impaired baroreflex sensitivity predicts outcome of acute intracerebral hemorrhage. Crit Care Med. 2008;36:3074–3079. doi: 10.1097/CCM.0b013e31818b306d.
    1. Sykora M, Diedler J, Rupp A, Turcani P, Steiner T. Impaired baroreceptor reflex sensitivity in acute stroke is associated with insular involvement, but not with carotid atherosclerosis. Stroke; J Cereb Circ. 2009;40:737–742. doi: 10.1161/STROKEAHA.108.519967.
    1. Sykora M, Steiner T, Poli S, Rocco A, Turcani P, Diedler J. Autonomic effects of intraventricular extension in intracerebral hemorrhage. Neurocrit Care. 2012;16:102–108. doi: 10.1007/s12028-011-9637-1.
    1. Takeda R, Ogura T, Ooigawa H, Fushihara G, Yoshikawa S, Okada D, Araki R, Kurita H. A practical prediction model for early hematoma expansion in spontaneous deep ganglionic intracerebral hemorrhage. Clin Neurol Neurosurg. 2013;115:1028–1031. doi: 10.1016/j.clineuro.2012.10.016.
    1. Takeuchi S, Nawashiro H, Wada K, Takasato Y, Masaoka H, Hayakawa T, Nagatani K, Otani N, Osada H, Shima K. Ventriculomegaly after decompressive craniectomy with hematoma evacuation for large hemispheric hypertensive intracerebral hemorrhage. Clin Neurol Neurosurg. 2013;115:317–322. doi: 10.1016/j.clineuro.2012.05.026.
    1. Tellez H, Bauer RB. Dexamethasone as treatment in cerebrovascular disease. 1. A controlled study in intracerebral hemorrhage. Stroke; J Cereb Circ. 1973;4:541–546. doi: 10.1161/01.STR.4.4.541.
    1. Thiex R, Tsirka SE. Brain edema after intracerebral hemorrhage: mechanisms, treatment options, management strategies, and operative indications. Neurosurg Focus. 2007;22:E6. doi: 10.3171/foc.2007.22.5.7.
    1. Thompson AL, Kosior JC, Gladstone DJ, Hopyan JJ, Symons SP, Romero F, Dzialowski I, Roy J, Demchuk AM, Aviv RI, Group PRSICS Defining the CT angiography ‘spot sign’ in primary intracerebral hemorrhage. Can J Neurol Sci Le journal canadien des sciences neurologiques. 2009;36:456–461. doi: 10.1017/S0317167100007782.
    1. van Asch CJ, Luitse MJ, Rinkel GJ, van der Tweel I, Algra A, Klijn CJ. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol. 2010;9:167–176. doi: 10.1016/S1474-4422(09)70340-0.
    1. Venkatasubramanian C, Mlynash M, Finley-Caulfield A, Eyngorn I, Kalimuthu R, Snider RW, Wijman CA. Natural history of perihematomal edema after intracerebral hemorrhage measured by serial magnetic resonance imaging. Stroke; J Cereb Circ. 2011;42:73–80. doi: 10.1161/STROKEAHA.110.590646.
    1. Wada R, Aviv RI, Fox AJ, Sahlas DJ, Gladstone DJ, Tomlinson G, Symons SP. CT angiography “spot sign” predicts hematoma expansion in acute intracerebral hemorrhage. Stroke; J Cereb Circ. 2007;38:1257–1262. doi: 10.1161/01.STR.0000259633.59404.f3.
    1. Wagner I, Hauer EM, Staykov D, Volbers B, Dorfler A, Schwab S, Bardutzky J. Effects of continuous hypertonic saline infusion on perihemorrhagic edema evolution. Stroke; J Cereb Circ. 2011;42:1540–1545. doi: 10.1161/STROKEAHA.110.609479.
    1. Wagner KR, Xi G, Hua Y, Kleinholz M, de Courten-Myers GM, Myers RE, Broderick JP, Brott TG. Lobar intracerebral hemorrhage model in pigs: rapid edema development in perihematomal white matter. Stroke; J Cereb Circ. 1996;27:490–497. doi: 10.1161/01.STR.27.3.490.
    1. Wang J, Dore S. Heme oxygenase-1 exacerbates early brain injury after intracerebral haemorrhage. Brain: J Neurol. 2007;130:1643–1652. doi: 10.1093/brain/awm095.
    1. Wang Y, Wang T, Zhang JH, Qin X. Effects of early serum glucose levels on prognosis of patients with acute intracerebral hemorrhage. Acta neurochir Suppl. 2011;111:393–397. doi: 10.1007/978-3-7091-0693-8_67.
    1. Wijdicks EF, Fulgham JR. Acute fatal deterioration in putaminal hemorrhage. Stroke; J Cereb Circ. 1995;26:1953–1955. doi: 10.1161/01.STR.26.10.1953.
    1. Wong AA, Henderson RD, O’Sullivan JD, Read SJ, Rajah T. Ring enhancement after hemorrhagic stroke. Arch Neurol. 2004;61:1790. doi: 10.1001/archneur.61.11.1790.
    1. Wu G, Xi G, Huang F. Spontaneous intracerebral hemorrhage in humans: hematoma enlargement, clot lysis, and brain edema. Acta neurochir Suppl. 2006;96:78–80. doi: 10.1007/3-211-30714-1_19.
    1. Wu H, Wu T, Xu X, Wang J, Wang J. Iron toxicity in mice with collagenase-induced intracerebral hemorrhage. J Cereb Blood Flow Metab: Off J Int Soc Cereb Blood Flow Metab. 2011;31:1243–1250. doi: 10.1038/jcbfm.2010.209.
    1. Wu J, Hua Y, Keep RF, Schallert T, Hoff JT, Xi G. Oxidative brain injury from extravasated erythrocytes after intracerebral hemorrhage. Brain Res. 2002;953:45–52. doi: 10.1016/S0006-8993(02)03268-7.
    1. Xi G, Keep RF, Hoff JT. Erythrocytes and delayed brain edema formation following intracerebral hemorrhage in rats. J Neurosurg. 1998;89:991–996. doi: 10.3171/jns.1998.89.6.0991.
    1. Xi G, Keep RF, Hoff JT. Mechanisms of brain injury after intracerebral haemorrhage. Lancet Neurol. 2006;5:53–63. doi: 10.1016/S1474-4422(05)70283-0.
    1. Xi G, Wagner KR, Keep RF, Hua Y, de Courten-Myers GM, Broderick JP, Brott TG, Hoff JT. Role of blood clot formation on early edema development after experimental intracerebral hemorrhage. Stroke; J Cereb Circ. 1998;29:2580–2586. doi: 10.1161/01.STR.29.12.2580.
    1. Yashon D, Kosnik EJ. Chronic intracerebral hematoma. Neurosurgery. 1978;2:103–106. doi: 10.1227/00006123-197803000-00004.
    1. Yildiz OK, Arsava EM, Akpinar E, Topcuoglu MA. Previous antiplatelet use is associated with hematoma expansion in patients with spontaneous intracerebral hemorrhage. J Stroke Cerebrovasc Dis: Off J Natl Stroke Assoc. 2012;21:760–766. doi: 10.1016/j.jstrokecerebrovasdis.2011.04.003.
    1. Yuguang L, Liangwen Z, Fusheng L, Shugan Z, Xingang L, Wandong S, Chengyuan W. Chronic expanding intracerebral hematoma. J Clin Neurosci: Off J Neurosurg Soc Australas. 2003;10:680–682. doi: 10.1016/j.jocn.2003.02.002.
    1. Zazulia AR, Diringer MN, Derdeyn CP, Powers WJ. Progression of mass effect after intracerebral hemorrhage. Stroke; J Cereb Circ. 1999;30:1167–1173. doi: 10.1161/01.STR.30.6.1167.
    1. Zhou X, Chen J, Li Q, Ren G, Yao G, Liu M, Dong Q, Guo J, Li L, Guo J, Xie P. Minimally invasive surgery for spontaneous supratentorial intracerebral hemorrhage: a meta-analysis of randomized controlled trials. Stroke; J Cereb Circ. 2012;43:2923–2930. doi: 10.1161/STROKEAHA.112.667535.

Source: PubMed

3
Subskrybuj